Quadrant Capital Group LLC
- SEC CIK
- 0001650717
- Latest filing
- Aug 14, 2026
ANIK holding history
Anika Therapeutics, Inc. in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ANIK overviewAll 13F holders of ANIKFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −326−100.0% | Sold out | Holders |
| Q3 2024 | 326 | $8.05K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 326 | $8.26K | <0.1% | −190−36.8% | Reduced | Holders |
| Q1 2024 | 516 | $13.1K | <0.1% | +190+58.3% | Added | Holders |
| Q4 2023 | 326 | $7.39K | <0.1% | +270+482.1% | Added | Holders |
| Q3 2023 | 56 | $1.04K | <0.1% | −1,148−95.3% | Reduced | Holders |
| Q2 2023 | 1,204 | $31.3K | <0.1% | +40+3.4% | Added | Holders |
| Q1 2023 | 1,164 | $33.4K | <0.1% | +12+1.0% | Added | Holders |
| Q4 2022 | 1,152 | $34.1K | <0.1% | +80+7.5% | Added | Holders |
| Q3 2022 | 1,072 | $26.0K | <0.1% | +1,043+3,596.6% | Added | Holders |
| Q2 2022 | 29 | $1.00K | <0.1% | +29 | New | Holders |